Invention Grant
- Patent Title: Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
-
Application No.: US15995323Application Date: 2018-06-01
-
Publication No.: US10695337B2Publication Date: 2020-06-30
- Inventor: Taisheng Huang , Chu-Biao Xue
- Applicant: Incyte Corporation , Incyte Holdings Corporation
- Applicant Address: US DE Wilmington US DE Wilmington
- Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee: Incyte Holdings Corporation,Incyte Corporation
- Current Assignee Address: US DE Wilmington US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61P17/04 ; A61K31/4545 ; C07D487/04 ; A61P1/00 ; A61P11/00 ; A61P35/00 ; A61P11/06 ; A61P27/02 ; C07D401/14 ; C07D405/14 ; A61K9/00 ; C07D519/00 ; C07D471/04
Abstract:
The present invention provides piperidin-4-yl azetidine derivatives, as well as their compositions and methods of use, that modulate the activity of Janus kinase 1 (JAK1) and are useful in the treatment of diseases related to the activity of JAK1 including, for example, inflammatory disorders, autoimmune disorders, cancer, and other diseases.
Public/Granted literature
- US20180353499A1 PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS Public/Granted day:2018-12-13
Information query
IPC分类:
